A detailed history of Values First Advisors, Inc. transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Values First Advisors, Inc. holds 5,769 shares of TMDX stock, worth $368,639. This represents 0.5% of its overall portfolio holdings.

Number of Shares
5,769
Previous 9,068 36.38%
Holding current value
$368,639
Previous $1.37 Million 33.7%
% of portfolio
0.5%
Previous 0.83%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$135.68 - $176.11 $447,608 - $580,986
-3,299 Reduced 36.38%
5,769 $905,000
Q2 2024

Jul 19, 2024

SELL
$72.62 - $150.62 $50,325 - $104,379
-693 Reduced 7.1%
9,068 $1.37 Million
Q1 2024

Apr 23, 2024

BUY
$70.86 - $89.93 $77,662 - $98,563
1,096 Added 12.65%
9,761 $721,000
Q4 2023

Jan 18, 2024

BUY
$36.74 - $81.08 $318,352 - $702,558
8,665 New
8,665 $683,000

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $2.03B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Values First Advisors, Inc. Portfolio

Follow Values First Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Values First Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Values First Advisors, Inc. with notifications on news.